No Detail Found!

Metabolic syndrome and antipsychotic drugs— a review.

Author(s)
Ami Shah Department of Psychiatry, Lokmanya Tilak Muncipal Medical College and General Hospital, Sion, Mumbai, India
Deepa Nair Department of Psychiatry, Lokmanya Tilak Muncipal Medical College and General Hospital, Sion, Mumbai, India
Gurvinder Kalra Department of Psychiatry, Lokmanya Tilak Muncipal Medical College and General Hospital, Sion, Mumbai, India
Avinash De Sousa Department of Psychiatry, Lokmanya Tilak Muncipal Medical College and General Hospital, Sion, Mumbai, India
Abstract
Metabolic syndrome is characterised by a constellation of obesity, dyslipidemia, insulin insensitivity, deranged glucose metabolism and hypertension. The interface between psychiatry and metabolic syndrome is of importance today due to the increasing recognition of this syndrome among patients receiving psychotropic medications. Antipsychotics and possibly other psychotropic drugs like antidepressants can induce weight gain or worsen other metabolic parameters, particularly increasing the cardiovascular risk factors. Mounting evidence has suggested decreased life expectancy in psychiatric patients by one to three decades. Changes associated with metabolic syndrome appear to play a significant role in them. This article reviews metabolic syndrome in association with psychiatric illnesses, antipsychotic treatment and recent guidelines for its detection and management.
Publication Details
Page(s) 53-61
DOI DOI not available
Published Journal: Journal of Pakistan Psychiatric Society, Volume: 9, Issue: 2, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

50

Views